In conclusion, our current data support the recent hypothesis that the activity of the RAAS and related autonomic characteristics may serve to define a form of depression, which can be targeted with an inhibitor of 11betaHSD2. This evidence concerns the gene HSD11B2 and depressive symptom measurement.